What label best describes this news article?
Big Pharma #39;s Rx to Rise and Shine Investors and insomniacs can rest easy: The Food  amp; Drug Administration approved Lunesta, Sepracor #39;s (SEPR ) new drug for sleeplessness, on Dec. 15. 